418 related articles for article (PubMed ID: 11034201)
1. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.
Lasorella A; Noseda M; Beyna M; Yokota Y; Iavarone A
Nature; 2000 Oct; 407(6804):592-8. PubMed ID: 11034201
[TBL] [Abstract][Full Text] [Related]
2. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.
Lasorella A; Boldrini R; Dominici C; Donfrancesco A; Yokota Y; Inserra A; Iavarone A
Cancer Res; 2002 Jan; 62(1):301-6. PubMed ID: 11782392
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of essential somatic cell cycle regulatory protein expression and implied activity occurs at the second to third cell division in mouse preimplantation embryos.
Xie Y; Sun T; Wang QT; Wang Y; Wang F; Puscheck E; Rappolee DA
FEBS Lett; 2005 Jan; 579(2):398-408. PubMed ID: 15642350
[TBL] [Abstract][Full Text] [Related]
4. Id2 is dispensable for myc-induced lymphomagenesis.
Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages.
Iavarone A; King ER; Dai XM; Leone G; Stanley ER; Lasorella A
Nature; 2004 Dec; 432(7020):1040-5. PubMed ID: 15616565
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
Fukuma M; Okita H; Hata J; Umezawa A
Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
[TBL] [Abstract][Full Text] [Related]
8. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of human c-fos expression by the retinoblastoma gene product.
Robbins PD; Horowitz JM; Mulligan RC
Nature; 1990 Aug; 346(6285):668-71. PubMed ID: 2117257
[TBL] [Abstract][Full Text] [Related]
10. [Id2, a go-between in the Myc-Rb pair].
Bénard J; Raguenez G; Douc-Rasy S
Bull Cancer; 2000 Dec; 87(12):877-80. PubMed ID: 11174116
[No Abstract] [Full Text] [Related]
11. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.
Lasorella A; Rothschild G; Yokota Y; Russell RG; Iavarone A
Mol Cell Biol; 2005 May; 25(9):3563-74. PubMed ID: 15831462
[TBL] [Abstract][Full Text] [Related]
12. Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium.
Russell RG; Lasorella A; Dettin LE; Iavarone A
Cancer Res; 2004 Oct; 64(20):7220-5. PubMed ID: 15492237
[TBL] [Abstract][Full Text] [Related]
13. p27kip1-independent cell cycle regulation by MYC.
Berns K; Martins C; Dannenberg JH; Berns A; te Riele H; Bernards R
Oncogene; 2000 Oct; 19(42):4822-7. PubMed ID: 11039898
[TBL] [Abstract][Full Text] [Related]
14. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
[TBL] [Abstract][Full Text] [Related]
15. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.
Rustgi AK; Dyson N; Bernards R
Nature; 1991 Aug; 352(6335):541-4. PubMed ID: 1865909
[TBL] [Abstract][Full Text] [Related]
16. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
18. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription.
Adnane J; Robbins PD
Oncogene; 1995 Jan; 10(2):381-7. PubMed ID: 7838535
[TBL] [Abstract][Full Text] [Related]
19. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
Jiang Z; Liang P; Leng R; Guo Z; Liu Y; Liu X; Bubnic S; Keating A; Murray D; Goss P; Zacksenhaus E
Dev Biol; 2000 Nov; 227(1):8-41. PubMed ID: 11076674
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
